Navigation Links
Spaulding Clinical Research Partners With Verified Clinical Trials Protecting Clinical Trials From Dual Enrollment
Date:4/23/2013

West Bend, Wisconsin, USA (PRWEB) April 23, 2013

Today, Spaulding Clinical Research, a change agent in the clinical research and medical device industries, announces a partnership with Verified Clinical Trials, the world's leader in the field of clinical trial database registries. This partnership demonstrates both companies commitment to improving research volunteer safety, while preserving data integrity in clinical trials.

"A significant number of research volunteers are attempting to dual enroll in clinical trials or are not waiting for the appropriate washout period. With our focus on delivering high-quality data to our study sponsors, we chose Verified Clinical Trials registry as a partner because of their extensive North American network and their scalability,” states Cassandra Erato, Director of Clinical Operations at Spaulding Clinical Research.

Mitchell D. Efros, MD, CEO of Verified Clinical Trials (VCT) states. “This partnership strengthens our network and adds improved quality to the trials conducted not only at Spaulding Clinical Research but at our partner sites across our network. Unfortunately, in just a short period of time we have stopped many participants from breaking the rules, putting both the volunteer and the study at risk."

To learn more about how Verified Clinical Trials and Spaulding Clinical Research’s partnership is making a difference, visit Verified Clinical Trials at Partnerships in Clinical Trials, April 22-24th, in Orlando.

About Spaulding Clinical Research, LLC
Spaulding Clinical Research, LLC (http://www.spauldingclinical.com) a change agent in the clinical research and medical device industries, is focused on driving perpetual value for their clients through technology and process innovation that delivers speed, unprecedented quality and lower costs.

About Verified Clinical Trials
Verified Clinical Trials, (VCT) (http://www.verifiedclinicaltrials.com) the world's leader in the field of clinical trial database registries, proactively improves research subject safety and data quality in clinical research trials by halting dual enrollment in clinical trials. With a web-based solution designed to enhance the quality of both early and late phase trials, VCT has the scalability to reach all sites nationally and globally and is HIPAA- and 21 CFR part 11-compliant.

Spaulding Clinical Media Contact                
Kathy Forde                                
Sr. Director of Marketing                    
Tel: (414) 303-1912                            
Email: kathy.forde(at)spauldingclinical(dot)com

Verified Clinical Trials Media Contact
Kerri Weingard, ANP
Chief Operating Officer
Tel: (516) 998-7499
Email: kweingard(at)verifiedclinicaltrials(dot)com

Read the full story at http://www.prweb.com/releases/VerifiedClinicalTrials/SpauldingClinicalResearch/prweb10659883.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Medrio, a Leading EDC and eClinical SaaS Provider for Clinical Research, Announces the Highly Anticipated Release of Medrio 8.1 with iPad Support
2. The American Society for Clinical Investigation and Doximity Build Interactive Community
3. Translating Preclinical Pharmacology to Clinical Activity with Myriad RBM’s Inflammation MAP
4. Verified Clinical Trials Exhibits at the Annual 2013 Partnerships In Clinical Trials to Discuss the Professional Research Subject and the Clinical Trial Database Registry
5. Infinata’s BioPharm Insight to Offer Exclusive Preview of 2013 Key Reports at the BIO International Conference and Partnerships in Clinical Trials
6. Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories
7. 4th Annual Advancing Global Clinical Trials Conference is Announced
8. Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections
9. Pre-Clinical Imaging (In vivo) Market - by Systems and Reagents - Competitive Analysis & Global Forecasts to 2017
10. TGen-Scottsdale Healthcare clinical trial results for BIND-014 presented at AACR 2013
11. Verified Clinical Trials (VCT) Will Co-Present With SAFE-BioPharma At Bio-IT World April 10th In Boston, MA Exploring Identity Management In eClinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017  Infectex Ltd., a ... today announced positive results of a Phase 2b-3 clinical ... regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 ... at Sequella, Inc. ( USA ) and ... A total of 140 patients were enrolled in a ...
(Date:3/24/2017)... March 24, 2017 Agenus Inc. (NASDAQ: AGEN), ... antibodies and cancer vaccines, today announced participation at the ...  Annual William Blair and Maidstone Life Sciences conference "Cancer ... in New York, NY . Agenus ... 29 at 9:40 am: Robert B. Stein , ...
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseq™ ... developed with input from industry experts to ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of the world,s ... systems, in terms of costs and resources. However, as the ... of innovative and efficient therapies that demonstrate higher chances of ... cancer treatments, a growing number of patients receiving immuno-oncology therapies ...
Breaking Biology Technology:
(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/13/2017)... FRANCISCO , Feb. 13, 2017  RSA ... centralized platform that is designed to enhance fraud ... latest release in the RSA Fraud & Risk ... enable organizations to leverage additional insights from internal ... tools to better protect their customers from targeted ...
Breaking Biology News(10 mins):